Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18626133 | 1.00 | DPP7 (0.31) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL5883471 | 0.98 | DPP7 (0.34) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL340060 | 0.98 | DPP7 (0.34) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL5883693 | 0.95 | — | — | |
| SCHEMBL339384 | 0.95 | DPP7 (0.35) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL25315899 | 0.95 | DPP7 (0.35) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL14861702 | 0.95 | DPP7 (0.35) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL25312712 | 0.95 | DPP7 (0.35) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL6567356 | 0.91 | DPP7 (0.33) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL25312085 | 0.88 | DPP7 (0.36) | DPP7MEN1KMT2AABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140087988-A1 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2014-03-27 | — | — | US | claimed |
| EP-2709584-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. Mane Fils (FR) | 2014-03-26 | — | — | EP | claimed |
| WO-2012156649-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2012-11-22 | — | — | WO | claimed |
| EP-2709584-B1 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V MANE FILS (FR) | 2018-06-06 | — | — | EP | disclosed |
| EP-2709584-B1 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V MANE FILS (FR) | 2018-06-06 | — | — | EP | disclosed |
| US-9593294-B2 | Sensory use of 6-cyclopentylidenehexane derivatives | V. MANE FILS (FR) | 2017-03-14 | — | — | US | disclosed |
| US-9593294-B2 | Sensory use of 6-cyclopentylidenehexane derivatives | V. MANE FILS (FR) | 2017-03-14 | — | — | US | disclosed |
| US-9593294-B2 | Sensory use of 6-cyclopentylidenehexane derivatives | V. MANE FILS (FR) | 2017-03-14 | — | — | US | disclosed |
| US-9593294-B2 | Sensory use of 6-cyclopentylidenehexane derivatives | V. MANE FILS (FR) | 2017-03-14 | — | — | US | disclosed |
| CN-103747774-A | Sensory use of 6-cyclopentylidenehexane derivatives | MANE FILS V | 2014-04-23 | — | — | CN | disclosed |
| US-20140087988-A1 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2014-03-27 | — | — | US | disclosed |
| EP-2709584-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. Mane Fils (FR) | 2014-03-26 | — | — | EP | disclosed |
| EP-2709584-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. Mane Fils (FR) | 2014-03-26 | — | — | EP | disclosed |
| WO-2012156649-A3 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2014-01-03 | — | — | WO | disclosed |
| WO-2012156649-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2012-11-22 | — | — | WO | disclosed |
| WO-2012156649-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2012-11-22 | — | — | WO | disclosed |
| WO-2012156649-A2 | SENSORY USE OF 6-CYCLOPENTYLIDENEHEXANE DERIVATIVES | V. MANE FILS (FR) | 2012-11-22 | — | — | WO | disclosed |
| WO-2009136281-A1 | NITRIC OXIDE DONATING PROSTAMIDES | NICOX S.A. (FR) | 2009-11-12 | — | — | WO | disclosed |
| US-7091357-B2 | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2006-08-15 | — | — | US | disclosed |
| US-20030225142-A1 | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225142-A1 | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies | CHRNA4, CHRNA2, CHRNA5 | DPP7 4496/4885MEN1 4484/4885KMT2A 2143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.